Limatoc, Ailene C.
HRN: 26-30-36 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/30/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/30/2024
01/06/2025
IVTT
500 Mg
Q6
Cap-HR
Waiting Final Action
Indication: EmpiricEmpirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes